Home > PJ (current issue) > News / News Centre | Search

PJ Online homeThe Pharmaceutical Journal
Vol 277 No 7409 p65
15 July 2006

This article
Reprint   Photocopy

  Acrobat Reader


News summary


Concern mounts over job security in PCTs

Pharmacists and other head office staff in primary care trusts across England are facing uncertainty over their futures in the run up to the reorganisation of PCTs. Last week, PCT staff classed as managers or administrators in Devon and Cornwall received a letter formally informing them that their jobs are potentially at risk.

Shailen Rao, head of medicines management at Hillingdon PCT and chairman of the Primary Care Pharmacists Association, told The Journal that there is a debate at the moment about where prescribing teams will sit after the reconfigurations.

“PCTs may wish to share strategic functions but may underestimate the need for strategic input in individual PCTs.”

He added that the arrival of practice-based commissioning and transfer of services from secondary to primary care will require greater input from primary care pharmacists to ensure that medicines management initiatives are supported. Mr Rao is also concerned that laying off pharmacy staff could be a false economy and that a wealth of knowledge and experience may be lost in the process.

Brain Curwain

Brain Curwain: danger of isolation

Brian Curwain, chief pharmacist at New Forest PCT and a member of the Royal Pharmaceutical Society’s Council, told The Journal that in Hampshire seven PCTs are merging to form one organisation. “There are five senior grade pharmacists within the seven PCTs. My guess is that there won’t be five jobs at that level within the new organisation.” He and his colleagues have already started working on a proposal for pharmaceutical support to the reconfigured PCT.

Dr Curwain predicts that the reconfiguration will not lead to job losses overall but that significant numbers of people might have their employment changed in one way or another. “For example, budgets currently funding PCT medicines management teams might be devolved to practice-based commissioning groups to buy local pharmaceutical support,” he says. He believes that if existing teams fragment, there is a danger of professional isolation and variable quality. “If this happens, those providing support to PCT pharmacists, such as the National Prescribing Centre, will have to ensure that they nurture their networks,” he added.

Reconfigured PCTs come into being on 1 October. The Journal understands that staff redundancies in Devon and Cornwall will be kept to an absolute minimum and, if suitable posts cannot be found for individuals, employment will be guaranteed until 30 June 2007. Staff providing front-line services will not be affected.

Back to Top


©The Pharmaceutical Journal